Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Intralipid is used to improve clinical outcomes in patients with myocardial injury or suffering from reperfusion injury after cardiopulmonary bypass following open heart surgery. Data supporting this practice is conflicting but suggestive of minimal benefit.